450 related articles for article (PubMed ID: 29468965)
1. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy.
Khan GJ; Sun L; Khan S; Yuan S; Nongyue H
Curr Drug Targets; 2018; 19(13):1573-1588. PubMed ID: 29468965
[TBL] [Abstract][Full Text] [Related]
2. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
3. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy.
Truffi M; Mazzucchelli S; Bonizzi A; Sorrentino L; Allevi R; Vanna R; Morasso C; Corsi F
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871158
[TBL] [Abstract][Full Text] [Related]
4. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
5. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.
Fiori ME; Di Franco S; Villanova L; Bianca P; Stassi G; De Maria R
Mol Cancer; 2019 Mar; 18(1):70. PubMed ID: 30927908
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Pradip D; Jennifer A; Nandini D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
[TBL] [Abstract][Full Text] [Related]
10. Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF).
Vancauwenberghe E; Noyer L; Derouiche S; Lemonnier L; Gosset P; Sadofsky LR; Mariot P; Warnier M; Bokhobza A; Slomianny C; Mauroy B; Bonnal JL; Dewailly E; Delcourt P; Allart L; Desruelles E; Prevarskaya N; Roudbaraki M
Mol Carcinog; 2017 Aug; 56(8):1851-1867. PubMed ID: 28277613
[TBL] [Abstract][Full Text] [Related]
11. miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.
Anajafi S; Paryan M; Khoshnazar A; Soleimani M; Mohammadi-Yeganeh S
Endocr Metab Immune Disord Drug Targets; 2024; 24(3):333-347. PubMed ID: 37612874
[TBL] [Abstract][Full Text] [Related]
12. In search of definitions: Cancer-associated fibroblasts and their markers.
Nurmik M; Ullmann P; Rodriguez F; Haan S; Letellier E
Int J Cancer; 2020 Feb; 146(4):895-905. PubMed ID: 30734283
[TBL] [Abstract][Full Text] [Related]
13. A centralized communication network: Recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors.
Leask A
Semin Cell Dev Biol; 2020 May; 101():111-114. PubMed ID: 31708414
[TBL] [Abstract][Full Text] [Related]
14. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
15. Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition.
Kim DJ; Dunleavey JM; Xiao L; Ollila DW; Troester MA; Otey CA; Li W; Barker TH; Dudley AC
Br J Cancer; 2018 May; 118(10):1359-1368. PubMed ID: 29695769
[TBL] [Abstract][Full Text] [Related]
16. Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression.
Jena BC; Das CK; Bharadwaj D; Mandal M
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188416. PubMed ID: 32822826
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
18. DT-13 inhibits breast cancer cell migration via non-muscle myosin II-A regulation in tumor microenvironment synchronized adaptations.
Gao Y; Khan GJ; Wei X; Zhai KF; Sun L; Yuan S
Clin Transl Oncol; 2020 Sep; 22(9):1591-1602. PubMed ID: 32056128
[TBL] [Abstract][Full Text] [Related]
19. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
20. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance.
Chandra Jena B; Sarkar S; Rout L; Mandal M
Cancer Lett; 2021 Nov; 520():222-232. PubMed ID: 34363903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]